Latest News

Oct 4

Planning to be in Boston October 26-28?

Come by and say hello and learn about some exciting new treatment options for your patients! Share in the latest information, innovative technologies, and best practices with some of the most renowned spine care professionals and scientists from around the world. For more information on Vivex’s creative treatment options and solutions, contact Michele…

Read More

May 17

Novastep, Inc. announced its entry into an agreement with Vivex Biomedical, Inc.

May 9, 2016 (GLOBE NEWSWIRE) – Novastep, Inc., and its affiliates (“Novastep” or the “Company”), a global medical technologies company specializing in foot and ankle implants, biologics, instrument systems and medical education programs, today announced its entry into an agreement with Vivex Biomedical, Inc., a privately held company focused on cellular therapies that…

Read More

Apr 20

Onkos Surgical Enters Into Partnership with Vivex Biomedical, Inc.

PARSIPPANY, N.J., April 19, 2016 /PRNewswire/ -- Onkos Surgical and Vivex Biomedical, Inc. have come together to provide a portfolio of tissue products to support the needs of musculoskeletal oncologists and their patients. This commitment strengthens Onkos Surgical's ability to enhance outcomes, decrease complications and improve recovery following musculoskeletal tumor and limb salvage surgery.…

Read More

Mar 31

Vivex Biomedical, Inc. and Arthrex, Inc. Enter into Long Term Agreement

MARIETTA, Ga., March 31, 2016 /PRNewswire/ -- Vivex Biomedical, Inc. and Arthrex Inc. have signed a new long-term agreement that strengthens the partnership between a leading provider of proprietary biologics and a premier innovator of orthopedic surgical solutions. The multi-year commitment reinforces the vision shared by Vivex Biomedical and Arthrex to progress clinical, surgical…

Read More

Mar 25

Xtant Medical Announces Distribution Agreement with Vivex Biomedical Bringing OsteoVive™, a Cellular Allograft, to Market

BELGRADE, Mont., March 24, 2016 EconoTimes -- Xtant Medical Holdings, Inc. (NYSE:XTNT), a leader in the development of regenerative medicine products and medical devices, is expanding its biologics portfolio through a distribution relationship with Vivex Biomedical, Inc., a leading processor of human tissue, synthetics, mimetic patterning technology, and biocellular products. Through this agreement,…

Read More